Evidence map›Paper›PMID 22580739›Full record

ArticleActa pharmacologica Sinica2012

Combined administration of anisodamine and neostigmine produces anti-shock effects: involvement of α7 nicotinic acetylcholine receptors.

Li Sun, Gu-fang Zhang, Xin Zhang, Qing Liu, Jian-guo Liu, Ding-feng Su, Chong Liu

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity.International journal of molecular sciences · 2014
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Li SunDepartment of Pharmacology, Second Military Medical University, Shanghai, China.
Gu-fang Zhang
Xin Zhang
Qing Liu
Jian-guo Liu
Ding-feng Su
Chong Liu
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the anti-effects of anisodamine and neostigmine in animal models of endotoxic and hemorrhagic shock.

methodsKunming mice were injected with lipopolysaccharide (LPS 30 mg/kg, ip) to induce endotoxic shock. Anisodamine (12.5, 25, and 50 mg/kg, ip) and neostigmine (12.5, 25, and 50 μg/kg, ip) were administered immediately after LPS injection. Survival rate was monitored, and the serum levels of TNF-α and IL-1β were analyzed using ELISA assays. The effects of anisodamine and neostigmine were also examined in α7 nicotinic acetylcholine receptor (α7 nAChR) knockout mice with endotoxic shock and in Beagle dogs with hemorrhagic shock.

resultsIn mice with experimental endotoxemia, combined administration of anisodamine and neostigmine significantly increased the survival rate and decreased the serum levels of inflammatory cytokines, as compared to those produced by either drug alone. The anti-shock effect of combined anisodamine and neostigmine was abolished in α7 nAChR knockout mice. On the other hand, intravenous injection of the combined anisodamine and neostigmine, or the selective α7 nAChR agonist PNU282987 exerted similar anti-shock effects in dogs with hemorrhagic shock.

conclusionThe results demonstrate that combined administration of anisodamine and neostigmine produces significant anti-shock effects, which involves activation of α7 nAChRs.

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorAnimalsAnti-Inflammatory Agents, Non-SteroidalCholinesterase InhibitorsDogsDrug Therapy, CombinationGene Knockout TechniquesHemodynamicsInterleukin-1betaLipopolysaccharidesLiverMiceMice, KnockoutNeostigmineReceptors, NicotinicShock, Hemorrhagicalpha7 Nicotinic Acetylcholine ReceptoranisodamineAnti-Inflammatory Agents, Non-SteroidalCholinesterase InhibitorsChrna7 protein, mouseInterleukin-1betaLipopolysaccharidesNeostigmineReceptors, NicotinicSolanaceous AlkaloidsTumor Necrosis Factor-alphaVasodilator Agents

Identifiers

PMID22580739
PMCPMC4010367
OpenAlexW2049532833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.